Specialty: Large Molecule

Frank Tagliaferri, PhD, is Chief Scientific Officer at Pace® Life Sciences, LLC. Frank leads the strategic advancement of the nationwide laboratory network to optimize current service offerings for sponsors as well as guide the investments in new capabilities across the drug development lifecycle.

Frank is highly experienced in protein and nucleic acid based therapeutics which allows him to both understand emerging product categories as well as evaluate the technologies and methodologies to allow Pace® to support effective research and development.

Frank received his PhD from the University of Virginia.